Hollow Brook Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
20,998
+648
| +3% | +$53.7K | 0.51% | 46 |
|
|
2025
Q1 | $1.65M | Sell |
20,350
-515
| -2% | -$41.8K | 0.48% | 44 |
|
|
2024
Q4 | $1.88M | Sell |
20,865
-804
| -4% | -$72.4K | 0.58% | 45 |
|
|
2024
Q3 | $2.14M | Buy |
21,669
+1,003
| +5% | +$99.1K | 0.63% | 43 |
|
|
2024
Q2 | $1.92M | Buy |
20,666
+1,504
| +8% | +$139K | 0.65% | 44 |
|
|
2024
Q1 | $1.82M | Buy |
19,162
+454
| +2% | +$43.1K | 0.67% | 41 |
|
|
2023
Q4 | $1.67M | Sell |
18,708
-41
| -0.2% | -$3.66K | 0.67% | 44 |
|
|
2023
Q3 | $1.37M | Buy |
18,749
+78
| +0.4% | +$5.7K | 0.57% | 47 |
|
|
2023
Q2 | $1.55M | Buy |
18,671
+535
| +3% | +$44.5K | 0.67% | 46 |
|
|
2023
Q1 | $1.38M | Buy |
18,136
+916
| +5% | +$69.8K | 0.65% | 42 |
|
|
2022
Q4 | $1.43M | Buy |
17,220
+354
| +2% | +$29.4K | 0.68% | 36 |
|
|
2022
Q3 | $1.34M | Buy |
+16,866
| New | +$1.34M | 0.76% | 36 |
|
|
2022
Q1 | – | Sell |
-8,603
| Closed | -$963K | – | 90 |
|
|
2021
Q4 | $963K | Buy |
8,603
+106
| +1% | +$11.9K | 0.49% | 45 |
|
|
2021
Q3 | $1.07M | Buy |
8,497
+742
| +10% | +$93.3K | 0.66% | 37 |
|
|
2021
Q2 | $1.05M | Buy |
7,755
+122
| +2% | +$16.5K | 0.65% | 32 |
|
|
2021
Q1 | $1.04M | Sell |
7,633
-596
| -7% | -$80.8K | 0.68% | 29 |
|
|
2020
Q4 | $1.16M | Sell |
8,229
-887
| -10% | -$125K | 0.69% | 31 |
|
|
2020
Q3 | $1.02M | Buy |
+9,116
| New | +$1.02M | 0.63% | 26 |
|